A research team from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), ...
Researchers at University Medical Center Utrecht have uncovered a previously underappreciated mechanism that helps immune ...
Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in sequencing-based analytics and AI-enabled design for RNA therapeutics, today announced the launch of eSENSE Break™, a sequencing-based ...
Decades of reliance on the antibiotic rifampicin have fueled the rise of drug-resistant Mycobacterium tuberculosis (Mtb). But ...
Soil salinity severely restricts grapevine growth by damaging roots, limiting shoot development, disturbing sodium/potassium (Na+/K+) balance, and weakening photosynthesis. Previous studies of ...
Researchers studying a 5300-year-old mummified man have identified bacteria that lived in his gut when he was alive, as well ...
Using patient-derived cardiac tissue and stem cell-based models, the team of translational researchers demonstrated that targeting the genetic cause of disease improved cellular abnormalities and ...
VERVE-102 is an investigational gene-editing treatment designed to permanently disable the PCSK9 gene in the liver, thereby ...
Using patient-derived cardiac tissue and stem cell-based models, the team of translational researchers demonstrated that targeting the genetic cause of disease improved cellular abnormalities and ...
One Nation wants to differentiate itself from the Liberals on energy at a time when the parties increasingly overlap on ...
GlobalData on MSN
ASCO26: In vivo oncology approaches continue to show promise
Lilly’s $7bn acquisition of Kelonia seems to be bearing fruit, with other in vivo approaches showing promise.
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results